Search published articles


Showing 1 results for Damavandi Kamali

Sedigheh Damavandi Kamali , Iliad Moradi , Abdolvahab Moradi ,
Volume 18, Issue 6 (Nov-Dec 2024)
Abstract

Background: Human papillomaviruses (HPVs) are DNA viruses from the Papillomaviridae family. These viruses are linked to about 5% of human cancers, with a significant association with cervical cancer. Infection with this virus can be screened in women to prevent cervical cancer.
Methods: This review analyzes articles published over the last two decades regarding self-sampling, papillomavirus, and cervical cancer. The search for articles was conducted using various scientific databases, with selections based on their relevance to the topic and their contribution to understanding and comparing methods. Key results were examined, focusing on social aspects, economic savings, and participants' satisfaction with the self-sampling method.
Results: One of the most common and effective methods for HPV screening is sampling from the cervix using the Pap smear method and molecular techniques, widely used in various countries. Currently, HPV screening methods in different countries are primarily limited to clinical sampling, which cannot cover all urban and rural populations. The World Health Organization has recommended and supported self-sampling for HPV screening as a new strategy.
Conclusion: This mini-review discusses the self-sampling method for HPV screening, its advantages, and its application in different countries. As self-sampling can address the needs of both rural and urban areas, it is more economically viable and helps minimize cultural barriers and public opinion challenges compared to clinical sampling. The HPV self-sampling strategy offers an effective and efficient method for HPV screening, aiming to cervical cancer caused by the HPV virus in various countries.


Page 1 from 1     

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.